Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Queen's University at Kingston

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 1841-10-16

Employees: 1K

Market Cap: -

Website: http://www.queensu.ca

Clinical Trials

Trimodality Therapy With/Out Durvalumab to Treat Patients With Muscle-Invasive Bladder Cancer

Phase 2

Active, not recruiting

Conditions: Bladder Cancer

Interventions: Drug: Durvalumab

First Posted Date: 2018-12-07

Last Posted Date: 2025-05-21

Lead Sponsor: Canadian Cancer Trials Group

Target Recruit Count: 82

Registration Number: NCT03768570

Locations: 🇨🇦
Tom Baker Cancer Centre, Calgary, Alberta, Canada
🇨🇦
Cross Cancer Institute, Edmonton, Alberta, Canada
🇨🇦
BCCA - Vancouver Cancer Centre, Vancouver, British Columbia, Canada

and more 28 locations

The Effect of Exercise on Recent Onset Low Back Pain in the Emergency Department

Not Applicable

Completed

Conditions: Low Back Pain

Interventions: Behavioral: Exercise
Behavioral: Advice to stay active and engaged in usual activities.
Other: Advise regarding use of medications
Behavioral: Advice on use of ice or heat

First Posted Date: 2018-11-28

Last Posted Date: 2019-03-25

Lead Sponsor: Queen's University

Target Recruit Count: 69

Registration Number: NCT03756519

Locations: 🇨🇦
Kingston Health Sciences Center - Kingston General Hospital and Hotel Dieu Hospital Sites, Kingston, Ontario, Canada

Ultrasound-guided Peripheral IV vs. Standard Technique in Difficult Vascular Access Patients by ICU Nurses

Not Applicable

Conditions: Difficult IV Access

Interventions: Device: Ultrasound

First Posted Date: 2018-11-19

Last Posted Date: 2019-02-12

Lead Sponsor: Queen's University

Target Recruit Count: 50

Registration Number: NCT03745209

Locations: 🇨🇦
Kingston General Hospital, Kingston, Ontario, Canada

Evaluating the Burst Pressure of Simulated Bowel Anastomosis Constructed Using the Reverse Half-Hitch Alternating Post Knots

Not Applicable

Completed

Conditions: Education, Medical
Surgery

Interventions: Other: RHAP Knot
Other: Square Knot

First Posted Date: 2018-11-15

Last Posted Date: 2019-02-11

Lead Sponsor: Queen's University

Target Recruit Count: 20

Registration Number: NCT03742583

Locations: 🇨🇦
Queen's Unviersity, Kingston, Ontario, Canada

Examining the Impact of Blood Flow Restricted Aerobic Exercise on PGC-1α mRNA Expression in Young Healthy Males

Not Applicable

Completed

Conditions: Mitochondrial Biogenesis

Interventions: Other: BFR Exercise
Other: CTL Exercise

First Posted Date: 2018-10-24

Last Posted Date: 2019-07-15

Lead Sponsor: Queen's University

Target Recruit Count: 13

Registration Number: NCT03717948

Locations: 🇨🇦
Queen's University, Kingston, Ontario, Canada

Optimizing Resource Utilization During Proficiency-based Training of Suturing Skills to Medical Students

Phase 3

Completed

Conditions: Education, Medical
Sutures

Interventions: Other: Method of learning simple interrupted sutures with instrument tie

First Posted Date: 2018-08-29

Last Posted Date: 2018-08-29

Lead Sponsor: Queen's University

Target Recruit Count: 44

Registration Number: NCT03650959

Locations: 🇨🇦
Queen's Unviersity, Kingston, Ontario, Canada

Comparing Conscious Sedation to Retrobulbar Block Anesthetics During Trans-scleral Diode Laser

Not Applicable

Completed

Conditions: Glaucoma

Interventions: Procedure: Remifentanil
Procedure: Retrobulbar Block

First Posted Date: 2018-08-24

Last Posted Date: 2018-08-28

Lead Sponsor: Queen's University

Target Recruit Count: 100

Registration Number: NCT03646500

Locations: 🇨🇦
Hotel Dieu Hospital, Kingston, Ontario, Canada

CFI-400945 in Patients With Advanced/Metastatic Breast Cancer

Phase 2

Active, not recruiting

Conditions: Breast Cancer

Interventions: Drug: CFI-400945

First Posted Date: 2018-08-10

Last Posted Date: 2025-02-17

Lead Sponsor: Canadian Cancer Trials Group

Target Recruit Count: 51

Registration Number: NCT03624543

Locations: 🇨🇦
Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario, Canada
🇨🇦
London Regional Cancer Program, London, Ontario, Canada
🇨🇦
Ottawa Hospital Research Institute, Ottawa, Ontario, Canada

and more 3 locations

CFI-402257 in Combination With Paclitaxel in Patients With Advanced/Metastatic HER2-Negative Breast Cancer

Phase 1

Active, not recruiting

Conditions: Breast Cancer

Interventions: Drug: CFI-402257
Drug: Paclitaxel

First Posted Date: 2018-06-26

Last Posted Date: 2025-03-25

Lead Sponsor: Canadian Cancer Trials Group

Target Recruit Count: 37

Registration Number: NCT03568422

Locations: 🇨🇦
BCCA - Vancouver Cancer Centre, Vancouver, British Columbia, Canada
🇨🇦
Kingston Health Sciences Centre, Kingston, Ontario, Canada
🇨🇦
Ottawa Hospital Research Institute, Ottawa, Ontario, Canada

and more 1 locations

Optimizing Prescribing of Antipsychotics in Long-Term Care

Not Applicable

Completed

Conditions: Dementia

First Posted Date: 2018-06-15

Last Posted Date: 2018-06-26

Lead Sponsor: Queen's University

Registration Number: NCT03557593

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy